Skip to main content
. 2013 Apr-Jun;17(2):263–272. doi: 10.4293/108680813X13654754535197

Table 1.

Characteristics of the 11 Patients with CSP-II

Patient Age, y Time of Previous Cesarean Section, y Gestational Age at Diagnosis, d Period of Vaginal Bleeding, d Treatment Before Hospitalization in Our Department Initial β-hCG Level, mIU/mL Hemoglobin, g/L Cardiac Activity in Gestational Sac (Y/N)a Diameter of Gestational Sac, cm Thickness of Myometrium of Anterior Lower Uterine Part, mma
1 35 1998 78 None Mifepristone, MTX 51,520 117 5.0 × 3.0
2 32 1998, 2002 53 13 Mifepristone 74,000 118 Y 2.8 3
3 30 2002, 2009 69 30 D&C 2104 60 N 4.5 × 4.5 × 3.8 (mass) Discontinuous myometrium
4 35 2001 55 1 None >15,000 135 Y 2.4 4
5 33 2008 58 4 None 7534 117 1.2 4
6 28 2000 48 10 D&C 5592 99 N 8.6 × 6.7 × 6.1 (mass)
7 27 2007 60 None None >15,000 97 Y 6.4 3
8 44 1997 50 7 None 5949 123 N 2.4 × 4 (mass) 2
9 38 2003 56 14 Mifepristone, D&C 14,203 98 N 4.3 × 3.2 (mass)
10 29 2005 50 None None >15,000 134 Y 3.5 1
11 34 2002 46 3 None 9843 121 2.5 2
a

Columns with dashes indicate where there was no information available.